SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway.
about
SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
SU6668 modulates prostate canc ...... ng MTDH/AKT signaling pathway.
@en
type
label
SU6668 modulates prostate canc ...... ng MTDH/AKT signaling pathway.
@en
prefLabel
SU6668 modulates prostate canc ...... ng MTDH/AKT signaling pathway.
@en
P2093
P2860
P356
P1476
SU6668 modulates prostate canc ...... ng MTDH/AKT signaling pathway.
@en
P2093
Benjiang Qian
Changming Liu
Huihong Chen
Huizhang Li
Jiabing Zhang
P2860
P304
P356
10.3892/IJO.2017.3926
P577
2017-03-22T00:00:00Z